Vascular endothelial growth factor in pleural effusions of different origin
about
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer.A case of cardiac amyloidosis with diuretic-refractory pleural effusions treated with bevacizumabSystemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancerDiagnostic accuracy of vascular endothelial growth factor for malignant pleural effusion: A meta-analysis.The value of matrix metalloproteinase-9 and vascular endothelial growth factor receptor 1 pathway in diagnosing indeterminate pleural effusion.Clinical implications for vascular endothelial growth factor in the lung: friend or foe?Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictionsThe role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusionA potential role for VEGF in the diagnostic approach of pleural effusions.Advances in the investigation and treatment of pleural effusions.Diagnostic molecular biomarkers for malignant pleural effusions.The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications.Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases.Systematic review and meta-analysis of vascular endothelial growth factor as a biomarker for malignant pleural effusions.Differential expression of vascular endothelial growth factor-A, -C and -D for the diagnosis and prognosis of cancer patients with malignant effusions.Addition of bevacizumab for malignant pleural effusion as the manifestation of acquired EGFR-TKI resistance in NSCLC patients.Secretion of IFN-γ Associated with Galectin-9 Production by Pleural Fluid Cells from a Patient with Extrapulmonary Tuberculosis.Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion.The importance of serum and pleural fluid level of vascular endothelial growth factor (VEGF) and VEGF fluid/serum ratio in the differential diagnosis of malignant mesothelioma-related pleural effusion.Role of bevacizumab in the management of the patient with malignant pleural effusion: more questions than answers.Effects of intracavitary administration of Endostar combined with cisplatin in malignant pleural effusion and ascites.A phase II study of cediranib as palliative treatment in patients with symptomatic malignant ascites or pleural effusion.Combination of DNA ploidy analysis and miR-21 or miR-24 in screening malignant pleural effusion.Clinical utility of vascular endothelial growth factor in diagnosing malignant pleural effusions.Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions.Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer.
P2860
Q33424301-BE19114B-8AC5-45C0-9B0C-6F7A88D583D9Q34512589-4ADE70DA-9414-4E3F-8346-264A4D743A63Q35995186-91885706-7A40-4135-A3F0-1DF57273742FQ36224809-C9265132-FD0A-43FF-9B70-4A15739D247FQ36599672-9485818A-41D7-444B-B2F9-76FE83DB5EA2Q36625050-81183A71-FF37-42A7-A3D5-F3DD1C70398DQ36901312-A03D3ED9-4546-45CE-8BA0-4A46401BCB9CQ36907325-C73BFCEA-15DC-4D99-8405-7465B0EEAE72Q37121504-CD4C18A6-F6B9-4275-B373-A460FB22F881Q37730006-A9261100-7BCC-4C44-B222-5907F32A487AQ37889963-3F4B1CDA-931D-4AEF-BEA4-BE961B1A7C13Q38058513-BFA174B6-521D-4112-8144-2BCF4C691913Q38672944-552E6B06-7754-4348-8F1C-4916F405140AQ39063366-70E963FD-0118-47AB-8B03-AB9118FABBCCQ40257822-8150B120-56E1-4A80-82EF-0E8E263C92AEQ41895086-CC14F1F5-A30D-4D43-BBBA-D4838F988176Q42339971-A617B23C-C94E-43FD-B7D8-A85B3B0AAA56Q46703298-A1D1488D-22E4-4FEE-8D9F-39FCC851B98EQ47141778-509BC81E-2FEE-43BB-8E1B-D989B8CEE85BQ47654289-D78F60C1-4D95-49A4-AA84-F7EA47E087C3Q48073500-3F2377F5-DAEB-439E-9797-1389F72497D7Q48093666-3D527192-BD52-470C-8F71-65817BA4A9B4Q50082763-344DD00A-2511-47C1-A4DE-31D410C38FAAQ51904516-A8E40C92-3F65-4E41-ABE4-9DC149A5BF5EQ52838958-CAC4AC96-D400-47A1-8E5E-B39C3E859663Q54318375-23A72780-A847-4E2E-9460-545748745DCF
P2860
Vascular endothelial growth factor in pleural effusions of different origin
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Vascular endothelial growth factor in pleural effusions of different origin
@ast
Vascular endothelial growth factor in pleural effusions of different origin
@en
Vascular endothelial growth factor in pleural effusions of different origin
@nl
type
label
Vascular endothelial growth factor in pleural effusions of different origin
@ast
Vascular endothelial growth factor in pleural effusions of different origin
@en
Vascular endothelial growth factor in pleural effusions of different origin
@nl
prefLabel
Vascular endothelial growth factor in pleural effusions of different origin
@ast
Vascular endothelial growth factor in pleural effusions of different origin
@en
Vascular endothelial growth factor in pleural effusions of different origin
@nl
P2093
P1476
Vascular endothelial growth factor in pleural effusions of different origin
@en
P2093
G Hoheisel
L Engelmann
M Hoffmann
P304
P356
10.1183/09031936.05.00037004
P407
P577
2005-04-01T00:00:00Z